bioMerieux Competitors and Similar CompaniesClear all

Danaher's competitors and similar companies include QIAGEN and Bio-Rad.

	Danaher Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies.	QIAGEN QIAGEN is a company that provides sample technology solutions.	Bio-Rad Bio-Rad Laboratories is a company that develops, manufactures, and sells life science research and clinical diagnostics products.
Founding Date	Founding Date 1984	Founding Date 1984	Founding Date 1952
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech medical devices medical diagnostics therapy	Tags Healthcare clinical research medical devices	Tags Healthcare biotech clinical research life sciences medical diagnostics
Locations	Locations Washington, US HQ Mount Waverley, AU Vienna, AT Ghent, BE Sao Paolo, BR Vancouver, CA Shanghai, CN see more	Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more	Locations Hercules, US HQ South Granville, AU South Granville, AU Wien, AT Lokeren, BE Temse, BE São Paulo, BR see more
Employees	Employees 60,0002% decrease	Employees 5,6541% decrease	Employees 7,4503% decrease
Valuation ($)	Valuation ($) 175.3 b	Valuation ($) 9.3 b	Valuation ($) 9.2 b
Financial
Revenue (est.)	Revenue (est.) $24.6b (FY, 2025)	Revenue (est.) $2.1b (FY, 2025)	Revenue (est.) $2.6b (FY, 2025)
Cost of goods	Cost of goods $10b (FY, 2025)	Cost of goods $577.3m (FY, 2025)	Cost of goods $1.2b (FY, 2025)
Gross profit	Gross profit $14.5b (FY, 2025)	Gross profit $1.5b (FY, 2025)	Gross profit $1.3b (FY, 2025)
Net income	Net income $3.6b (FY, 2025)	Net income $437m (FY, 2025)	Net income $759.9m (FY, 2025)
Operating ⚠
Countries	Countries 50 (FY, 2023)	Countries N/A	Countries 35 (Q1, 2023)
Remaining Performance Obligations	Remaining Performance Obligations $4.5b (Q2, 2024)	Remaining Performance Obligations $72m (FY, 2024)	Remaining Performance Obligations N/A